
40 episodes

Speaking of SurgOnc Annals of Surgical Oncology and Society of Surgical Oncology
-
- Science
-
-
5.0 • 6 Ratings
-
"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.
-
Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy with and without Reconstruction
Rick Greene, MD, and Audree Tadros, MD, MPH, FACS, discuss the BREAST-Q, a validated patient-reported outcome measure for satisfaction and quality of life after breast surgery, to determine whether patient satisfaction and quality of life differs among T4 breast cancer patients based on their decision to pursue reconstruction and the timing of reconstruction. Dr. Tadros is author of “Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy with and without Reconstruction.”
Dr. Audree Tadros is the Jeanne A. Petrek Junior Faculty Chair, Memorial Sloan-Kettering Cancer Center, New York, and Assistant Attending Surgeon, Memorial Sloan-Kettering Cancer Center, New York, NY. -
Disparities in Utilization and Outcomes of Minimally Invasive Techniques for Gastric Cancer Surgery in the United States
Rick Greene, MD, discusses with Joon Park, MD, the national implementation patterns and perioperative outcomes of minimally invasive gastrectomy in gastric cancer surgery in the US. Dr. Park is author of “Disparities in Utilization and Outcomes of Minimally Invasive Techniques for Gastric Cancer Surgery in the United States.”
Dr. Joon Park is a Resident of Surgery in the Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA. -
Surgical Approach Does Not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched Study
Dr. Rick Greene and Dr. Fadi Dahdaleh discuss the effect of operative approach on overall readiness to commence adjuvant therapy in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy, hypothesizing that minimally invasive pancreaticoduodenectomy improves rates and time to return to intended oncologic therapy compared with open pancreaticoduodenectomy. Dr. Dahdaleh is author of “Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched Study.”
Dr. Dahdaleh is an attending surgical oncologist at Northshore-Edward-Elmhurst Health in Chicago and adjunct clinical assistant professor of surgery at Rush Medical College, Chicago, IL. -
Downstaging of Pancreatic Adenocarcinoma with Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival
Rick Greene, MD, discusses with Anne O’Shea, MD, and Timothy Vreeland, MD, the role of neoadjuvant chemotherapy or chemoradiation in the treatment of localized pancreatic adenocarcinoma, and the effect of downstaging on overall survival. Dr. O’Shea and Dr. Vreeland are authors of “Downstaging of Pancreatic Adenocarcinoma with Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival.”
Dr. Anne O’Shea is Resident of Surgery in the Department of Surgery at Brooke Army Medical Center, Ft. Sam, San Antonio, TX. Dr. Timothy Vreeland is a Surgical Oncologist also at the Brooke Army Medical Center, Ft. Sam, San Antonio, TX. -
The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy
Rick Greene, MD, Alexandra Gangi, MD, and Rupen Shah, MD, discuss the landmark articles on which management of primary appendiceal peritoneal surface malignancies are based. Drs. Gangi and Shah are authors of, “The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy."
Dr. Gangi is Director or the Gastrointestinal Tumor and Cancer Regional Therapies Programs, and Associate Program Director, Complex General Surgical Oncology Program, Division of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, CA. Dr. Rupen Shah is Director, Peritoneal Surface Malignancy Program and senior staff surgical oncologist at the Henry Ford Cancer Institute, Detroit, MI. -
Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?”
Rick Greene, MD, and Samilia Obeng-Gyasi, MD, MPH, discuss the effect of Medicaid expansion under the Affordable Care Act on patterns of surgical care among low-income breast cancer patients. Dr. Obeng-Gyasi is author of “Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?”
Dr. Obeng-Gyasi is Assistant Professor of Surgery in the Division of Surgical Oncology at The Ohio State University, Columbus, OH.